Abstract: Traumatic brain injury (TBI) remains the main cause of disability and a major public health problem worldwide. This review focuses on the neurophysiology of TBI, and the rationale and current state of evidence of clinical application of brain stimulation to promote TBI recovery, particularly on consciousness, cognitive function, motor impairments, and psychiatric conditions. We discuss the mechanisms of different brain stimulation techniques including major noninvasive and invasive stimulations. Thus far, most noninvasive brain stimu lation interventions have been nontargeted and focused on the chronic phase of recovery after TBI. In the acute stages, there is limited available evidence of the efficacy and safety of brain stimulation to improve functional outcomes. Comparing the studies across different techniques, transcranial direct current stimulation is the intervention that currently has the higher number of properly designed clinical trials, though total number is still small. We recognize the need for larger studies with target neuroplasticity modulation to fully explore the benefits of brain stimulation to effect TBI recovery during different stages of recovery.
Introduction
Traumatic brain injury (TBI) is one of the leading causes of disabilities and death of young adults. It is estimated that 1.7 million cases occur each year in the United States, in which nearly 80% are treated and released from an emergency department. 1 Cogni tive impairment and neuropsychiatric disorders are the main disabilities, [2] [3] [4] followed by motor deficits. 5 To date, there is no optimal pharmaceutical treatment for acute TBI, 6 and brain stimulation techniques appear promising as treatment options to improve neuropsychiatric conditions and motor deficits. 7 Our review presents the underlying neuroplasticity mechanisms and maladaptive plasticity involved in stages of recovery of TBI. It focuses on the primary and secondary injury phases. To better understand the mechanism, rationale, and current clinical evidence of noninvasive and invasive brain stimulation, we will provide a comprehensive review on how stimulation techniques modulate brain activity, promote recovery, and prevent further damage after TBI.
The primary injury phase in TBi
Depending on the mechanism of the trauma, the immediate insult to the brain might be focal (subdural, subarachnoid, or epidural hematoma/hemorrhage/contusion), diffuse (wide spread disruption of neuronal circuitry/axonal injury), or mixed (diffuse axonal injury with intracerebral hemorrhage). The initial neuronal injury occurs instantly 10 and oftentimes causes irreversible damage to the central nervous system, due to impairment of neuronal cell functions or cell death. 11 Irre versible damage occurs due to the impact of a traumatic event at the origin of acceleration-deceleration shearing, or pen etrating injury to the tissues and structures of the brain. Initial shearing of axons and blood vessels can cause intracerebral bleeding, which leads to parenchymal hemorrhage resulting in mass effect 10 to the brain tissue. In diffuse axonal injury 10 there is deformation to complete disruption of the axons. This disruption/deformation causes loss of connectivity between different areas of the brain, and can negatively impact neural regeneration, leading to dysfunctional interactions. Thus, even a relatively local lesion can lead to extensive functional damage of other areas of the brain. 12 The secondary injury phase in TBi
As a result of an early reduction of cerebral vascular auto regulation and loss of blood-brain barrier integrity, gradual diffuse microvascular damage occurs. 13 This diffuse damage increases the risk of ischemic injury and leads to cellular death. 11 Other changes include release of neurotransmitters, decreased glucose utilization, lactic acid accumulation, reduced activity of adenosine triphosphate (ATP)reliant ion pumps, increased release of glutamate, Ca 2+ induced depolarization, and excitotoxicity. All of these changes may cause anatomical and functional modifications of synaptic transmission. 14 The modulation of the series of actions on a synaptic transmission is an important way to promote brain plasticity.
In the first few weeks after brain injury, brain plasticity and functional recovery involve resolution of edema and inflammation. 15 After this initial period, neuroplasticity and remyelination are the most important alterations occurring within the first 3 months after injury. 15 It is in the acute and subacute stages that there is greatest potential for modifica tion of neural networks, leading to the formation of new anatomical neural connections. 16 Therefore, the improvement of function after TBI needs to be targeted at different points in time. In the acute phase, inhibition of glutamatergic neural activity may reduce neurologic injury. 17 In the subacute phase, modulation of gamma aminobutyric acid (GABA)ergic suppression may be crucial to minimize the insult and promote recovery. In the chronic phase, modulation of neuroplasticity is desirable to inhibit maladaptive changes and to promote neural network connections. Ultimately, the final outcome in any stage of injury is to maximize functional recovery. A comprehensive review of the neuroplasticity of TBI can be found in Villamar et al. 14 In the following "Methods" section, we will discuss the mechanism, rationale, and cur rent evidence of noninvasive and invasive brain stimulation techniques.
Methods
We searched PubMed (1960 PubMed ( -2015 , CINAHL (1984 CINAHL ( -2015 , ClinicalKey (2012 ClinicalKey ( -2015 , EMBASE (1974 EMBASE ( -2015 , and OVID databases . As search term keywords, we used: "Transcranial Magnetic Stimulation (TMS)", "Transcranial Direct Current Stimulation (tDCS)", "Transcranial LowLevel Light/Laser Therapy (LLLT)", "Transcranial LightEmitting Diode (LED)", "Deep Brain Stimulation (DBS)", "Disorders of Consciousness (DOC)", and "Traumatic Brain Injury (TBI)". Based on our search, 37 clinical studies were included in this review.
Noninvasive brain stimulation
Noninvasive brain stimulation (NIBS) has the ability to modulate neuron firing. It increases synaptic strength, modulates neurotransmitters and excitotoxicity, and modi fies neural network connections, and is therefore a promising therapeutic intervention for TBI. The NIBS methods used to modulate brain plasticity discussed in this article include TMS, tDCS, LLLT, and LED.
TMS
TMS is a NIBS instrument that induces electrical currents via Faraday's principle of electromagnetic induction. Since its first clinical use in 1985 by Barker et al 18 the variety of neuropsychiatric conditions being treated by TMS has increased tremendously. 19 The coil placed on the scalp gener ates a magnetic field that induces a flow of an electric current to neural tissue. This type of stimulation can depolarize/ hyperpolarize targeted stimulated areas. For this purpose, there are several protocols of singlepulse and pairedpulse TMS. Thus, TMS may be used as a diagnostic tool to 
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Traumatic brain injury and utility of brain stimulation modalities evaluate the integrity of the corticospinal tract, spinal cord, and peripheral nerves.
If TMS is used repetitively, ongoing changes in neuronal excitability can be facilitated or inhibited. Those effects are dependent on stimulation parameters. Lowfrequency repeti tive TMS (rTMS; 1 Hz) is known to reduce the neural activity in the direct stimulated cortical areas, while highfrequency (.5 Hz) TMS generally increases the neural activity. Repeti tive rTMS can modulate the activity of the functionally con nected brain regions, reorganizing the neuronal network after injury. 20 Theta burst stimulation (TBS) -a mode of patterned rTMS -can modulate cortical excitability. 21 This stimulation can be given continuously (cTBS) or intermittently (iTBS). When given continuously, it decreases cortical excitability and given intermittently, it facilitates cortical excitability.
The short effects of TMS on brain activity are partially induced by changes in flow of ionic concentration affecting the synaptic activity in the stimulated area.
14 The modulatory effects of TMS can outlast the duration of its application. The aftereffect duration is influenced by the magnitude and frequency of stimulation. 20 Longterm effects are the result of longterm potentiation (LTP)/longterm depres sion (LTD), which are mechanisms involved in learning. Therefore improvements in cognitive performance are the result of long lasting changes in synaptic strength induced by cumulative effects of consecutive sessions of rTMS. TMS can also mediate release of glutamate or GABA, which may be the reason for its therapeutic effects. 14 
Clinical results
Our review of the literature yielded seven clinical studies in which, five studies [21] [22] [23] [24] [25] are case reports, one is an open label study, 26 and one is a crosssectional survey. 27 None of the studies addressed use of TMS in the acute phase. Details are included in Table 1 .
Case reports using TMS addressed neurobehavioral improvements in chronic TBI patients. The aims of these stud ies were to reduce music hallucinations, 24 promote tinnitus relief, 25 and decrease depression symptoms 22 by using low frequency rTMS. Highfrequency rTMS 23 and cTBS 21 were used to improve consciousness 23, 27 and visuospatial neglect, 21 respectively. After the stimulation, the outcomes were reduc tion of depressive symptoms, 22 visuospatial neglect, 21 and tinnitus. 25 In regards to improvement of consciousness 23 and music hallucinations, 24 there were only shortterm effects observed.
The number of treatment sessions in these studies varied from 10 to 30 sessions. Targeted areas involved the dorsolateral prefrontal cortex (DLPFC), 22, 23, 26 and the temporal [24] [25] [26] and posterior parietal cortex. 21 Only two cases used target neuro navigated rTMS. 22, 24 The largest TMS study was an open label study with 15 mild TBI patients; however, only 12 patients completed the protocol. 26 In this study, patients received 20 sessions of high frequency rTMS (10 Hz) at 110% motor threshold over the left DLPFC. The aim of the study was to alleviate postconcussion syndrome (PCS) symptoms, with positive results observed. Reported side effects included headache and sleep disturbances. 26 These studies showed potential benefits of TMS in improving neural conductivity by means of recruitment of neurons, axons, and/or dendritic circuits. Thus far, studies with TMS have included highly variable parameters of stimulation (frequency, number of sessions, treatment dura tion) and targeted areas. As a consequence of the variability, it is still unclear which TMS protocol is more effective. An important issue that deserves attention is the safety of the method. In the reviewed studies, the side effects were tran sient and no seizures were reported. A major limitation of these studies is that they were all case reports or case series without sham rTMS to verify the findings.
tDCS
Current modulation of human brain function was first described over 200 years ago, 28 and the description was further developed in the animal model in the 1950s and 1960s. [29] [30] [31] [32] [33] tDCS has been used as a NIBS technique, by means of two comparatively large rubber electrodes (25-35 cm 2 ) placed on the scalp. This allows a weak cur rent (1 mA-2 mA) to stream from the anode to the cathode. This stimulation is generally applied for 10-20 minutes. Even though the brain scalp absorbs most of the current, the electrical current that reaches the cerebral cortex has sufficient intensity to modify the resting membrane potential and to modulate the activity level of spontaneous excitatory neurons. Therefore, tDCS is regarded as a neuromodulatory NIBS technique. 34 Shortterm effects of tDCS may be induced by non synaptic mechanisms due to neuronal resting membrane depolarization. Such changes may alter the transmembrane proteins and electrolysisrelated hydrogen ions. 35 It has been reported that a 13minute, single session of tDCS can lead to a 90minute period of cortical excitability poststimulation. 36 Consecutive sessions of tDCS can prolong those effects for weeks. 37 Longterm effects may be associated with LTP and LTD mechanisms. 38 Such longterm effects are dependent 
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Traumatic brain injury and utility of brain stimulation modalities on modulation of NMethylDaspartate (NMDA) recep tor activation, as well as neuronal hyperpolarization and depolarization. Previous studies [35] [36] [37] showed that anodal tDCS increases the excitability of the cerebral cortex, and that cathodal stimulation decreases it. On a behavioral level, anodal tDCS may improve motor task performance, language, and memory. In contrast, cathodal tDCS may also increase performance by decreasing overactivation in an area of maladaptive plasticity.
Clinical results
Due to steady maturation of the technology, relatively low cost, and the ease of use there is increased interest in the potential application of tDCS for treatment of TBI. Our liter ature review yielded no clinical research on tDCS during the acute phase of TBI. Table 2 details seven tDCS studies. [39] [40] [41] [42] [43] [44] [45] Six clinical studies were found in the chronic phase of TBI, and there was only one study 39 in the subacute phase. In con trast to TMS studies, most tDCS studies were randomized controlled trials or crossover studies. Outcome measures in most of the studies were changes in consciousness and cog nitive performance. [40] [41] [42] [43] [44] The first pilot study was designed to assess whether anodal tDCS applied to left DLPFC could improve attention in patients with chronic TBI compared to sham stimulation. 40 Nine patients received anodal tDCS (2 mA for 20 minutes) or sham stimulation (2 mA for 1 minute), in a doubleblind, crossover manner with inter vals of at least 48 hours. 40 It was found that anodal tDCS applied to left DLPFC can significantly shorten reaction times when compared to sham. Two randomized controlled trials have explored whether successive applications of anodal tDCS (15 or 10 sessions of 1 mA for 10 minutes) placed over the left DLPFC would promote changes in attention control and memory track formation in severe TBI. 39, 41 Those trials revealed no significant improvement in cognitive outcome measures. 39, 41 However, in one study there were changes in electroencephalography (EEG) recordings associated with an LTPlike mechanism in neural networks, and this method was more likely to be sensitive enough to detect cortical changes than attention/ working memory performance. 41 One doubleblind sham controlled crossover study provided Class II evidence that shortduration tDCS over the left DLPF cortex transiently improves consciousness as measured by Coma Recovery Scale -Revised (CRSR) assessment in patients with mini mally conscious state (MCS). 43 The variance of results of all trials is likely to be related to the differences on number of sessions and timing of application during TBI recovery (chronic vs subacute). In conclusion, the potential application of tDCS as a neu romodulatory tool for blocking or suppressing maladaptive plasticity is still unknown.
In regards to motor function recovery after TBI, we found one study that included chronic TBI participants among stroke patients. All patients received bihemispheric tDCS over M1 paired with standard upper extremity physical therapy (24 sessions of 40 minutes, three times per week). They monitored lasting motor function improve ment 45 and reported positive results 6 months after tDCS stimulation.
LLLT and transcranial light-emitting diode
LLLT is a NIBS technique used to stimulate biological reactions 46 typically used in the recovery of neuropsychi atric conditions. 47, 48 LLLT uses lowpowered laser light at wavelengths from 632-1,064 nm, ranging from 1-1,000 mW. In acute phase after TBI, a decrease in energy transduc tion and ATP levels occur due to excessive calcium in the mitochondria within nerve cells impairing the oxidative phosphorylation process. The mechanisms involved in LLLT include the modulation of neurobiological function by improving mitochondrial function, promoting increased ATP and release of nitric oxide locally. This process enhances regional cerebral blood flow and brain oxygen, thereby augmenting metabolic capacity. 49, 50 Lightmodulated cell adhesion and proliferation can be increased or decreased depending on wavelengths used and radiation dose. 51 Recently, lightemitting diodes (LEDs) have been used as an alternative light source for LLLT. 51, 52 Rojas et al 53 were the first to record LLLT transcranial tissue response in vivo. They observed brain metabolic and antioxidant beneficial effects measured by increases in cytochrome oxidase expression in neuronal cultures. LLLT induced upregulation of cytochrome oxidase in the cortex plays a key role in neuronal physiology, serving as an interface between oxidative energy metabolism and cell survival signaling pathways. 54, 55 In addition, LLLT partially restores enzyme activity obstructed by potassium cyanidea cytochrome oxidase inhibitor -reducing neuronal cell death caused by this mitochondrial toxin. 52 This enzymatic restoration improves cellular activity of brain tissue that has been damaged by TBI. 45 Thereby, transcranial LLLT may become a novel therapy to enhance cognitive performance; emotional functions; and neurological conditions 47, 56 linked to mitochondrial dysfunction, 47 a ubiquitous finding in brain injury due to TBI. Animal studies showed benefits in laser phototherapy in damaged TBI cerebral tissue. Those benefits were smaller lesions, [57] [58] [59] improved motor behavior performance, 60 increased neurogenesis, 56 and changes in biochemical levels. 61 
Clinical results
To the best of our knowledge, there are only three clinical studies 48, 51, 62 published using light therapy (LLLT and LED) in patients with TBI. Table 3 details the manuscripts that evaluated those clinical findings. They were either case reports or open label studies. Nawashiro et al 62 studied bilat eral transcranial LED irradiation in a patient with persistent vegetative state (VS) following severe TBI. They applied the technique to the forehead of the patient to quantify changes in cerebral blood flow. Singlephoton emission comput erized tomography (SPECT) analysis showed unilateral increase in cerebral blood flow after 30 minutes of LED therapy applied twice a day. Stimulation on left DLPFC was felt to be responsible for improved akinesia in this patient. Naeser et al 51 described two cases of chronic mild TBI. The first case was a patient with chronic attentional problems after 7 years of injury. After 8 weeks of LED treat ment applications, there was an improvement of attention. This improvement was observed to gradually decline with interruption of treatment for 2 weeks. The second case was a patient treated after multiple concussions who stopped working due to cognitive dysfunction. After 4 months of LED treatment, the patient reportedly returned to full time work.
Naeser et al 48 examined the effect of two identical LED console units placed over the frontal, parietal, and temporal areas in eleven chronic mild traumatic brain injury patients in an openprotocol study. Their study suggested a reduction in posttraumatic stress symptoms and an improvement in working memory and executive functions after treatment application. Those improvements were still reported at 2month followup.
DBS for TBi
In contrast to noninvasive methods, deep brain stimulation (DBS) is a neurosurgical technique that consists of electri cal stimulation through electrodes surgically implanted to subcortical areas. In some neurological conditions, DBS is one of the main procedures in functional neurosurgery. 63, 64 In patients refractory to drug treatment, DBS is the gold standard for the treatment of motor symptoms of Parkinson's disease. 64, 65 This surgery involves the implantation of elec trodes through electrical conductors in the basal ganglia in both hemispheres. 64, 65 The areas usually targeted are the thalamus, subthalamic nuclei, and the globus pallidus. Those areas are subjected to electrical signals that stimulate or inhibit neuronal activity on these nuclei and associated circuitry. [65] [66] [67] The electrodes uses highfrequency stimulation of 70-185 Hz and amplitudes of 0.75-4 V. [66] [67] [68] [69] [70] This technique has greater potential for serious complications and psychiatric and cognitive side effects due to the current spread into brain structures surrounding the electrode. Accordingly to Wolz et al 71 the side effects may be due to electrode malposition. Therefore, in patients with TBI, 72, 73 clinical application of DBS has been less investigated. This technique has been approved by the US Food and Drug Administration (FDA) for the treatment of disabling symptoms of essential tremor and advanced Parkinson's disease, and is also approved for dystonia and obsessive compulsive disorder. 71 In Europe, in addition to these indications, it is used in epilepsy. 72 Research has indicated potential positive outcomes for chronic pain, 
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Li et al affective disorders, and a small cohort of patients in minimum state of consciousness. 73 Despite application for symptomatic posttraumatic dis eases such as tremor, [73] [74] [75] [76] Parkinsonism, 77 and hemidystonia, 68 there is expectation that the use of DBS might be also ben eficial to improve cognitive and consciousness deficits in TBI patients.
73-77

Clinical results
We found 20 studies [68] [69] [70] 75, [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] testing DBS in chronic TBI patients. Table 4 caused by various kinds of brain damage. One of these studies 82 described that eight of the 21 patients emerged from the VS and became able to obey verbal commands. The criticism of this study arises from the inclusion of patients 4-8 months following injury during a period of spontaneous recovery. Clinical improvements observed in these studies were based on small series or case reports. There are many variables in which functional and biological aspects warrant further investigation. The precise targets in patients with important anatomical injuries need to be defined before DBS can take a therapeutic role in clinical practice in patients with TBI. Some studies were related to improvement of movement disorders, [68] [69] [70] 75, 77, 79, 89, 91, 92 pain, 70, 86 and selfmutilation. 87 The main targets of those studies were the internal globus pallidus and the ventralis intermedius nucleus. The target for selfmutilation symptoms was the posterior hypothalamus. Some studies reported delayed complications, particularly infarction and infection. 68, 77, 78 Animal studies showed that vagus nerve stimula tion, another type of invasive stimulation, 93 could improve the prognosis of TBI. Since this technology has not been used in clinical studies, it was not included in this review.
Discussion
We discuss our findings in four separate sections: 1) the "Brain stimulation and biomarkers" section; 2) the "Clini cal outcomes and recovery" section; 3) the "Comparison of techniques: which one is better for TBI?" section; and 4) the "Safety" section.
Brain stimulation and biomarkers
There are specific types of biomarkers that assist with find ing a prognosis, response to treatment, and extent of TBI.
Although their utility is clear, there are limited data regard ing their reliability as a clinical tool and what the optimal biomarker is in TBI. We discuss a few biomarkers that are currently being tested.
Commonly tested biomarkers are either proteomic, genetic, or observed changes in brain metabolism. 94 Changes in motor evoked potential via single or paired pulse stimulation and effects of rTMS measured by changes in metabolic activity or cerebral oxygen levels using neuroimaging techniques 95 can be considered neurophysiologic biomarkers.
EEG is another potential biomarker. It provides variation in brain activity during stimulation via tDCS or rTMS. There is a suggestion that changes on EEG frequencies, particularly decrease in delta and increase in alpha, can be a biological marker for response of anodal tDCS reflecting increased corti cal activity. 39 The technique that has been more studied with biomarkers in TBI is DBS. Unlike NIBS techniques, DBS enables more precise access to target structures. It uses electrophysiological effects on feedback control as a biomarker to establish the timing and intensity of stimulation. In addition to changes in brain signals, functional magnetic resonance imaging (fMRI) has also been used to assess cerebral activity related to posttraumatic Parkinsonism symptoms. 96 In summary, EEG and neuroimaging are reliable meth ods to reflect the effects of brain stimulation and could be suitable biomarkers. These markers indicate correlations between structural lesions, metabolic dysfunction, and corti cal activity.
Clinical outcomes and recovery
Numerous studies have implied a relationship between clinical severity measures (eg, the Glasgow Coma Scale [GCS] and duration of posttraumatic amnesia [PTA] ) and various types of functional outcome measures at differ ent times after brain injury. 97 All protocols in this review addressed the subacute or chronic phase of recovery and used different outcome measures, varying from clinical to functional scores.
While neuroimaging as an assessment tool can provide insights into potential relationships between the GCS, PTA, cognitive function, and outcome after TBI, 98 it does increase cost. Only four TMS studies assessed functional recovery assisted with neuroimaging technologies, such as positron emission tomography (PET) and resting fMRI. 21, 22, 24, 26 The clinical endpoints in those studies were related to clinical neu robehavioral improvements and also other clinical outcomes, such as transitory reduction of music hallucinations. 
DBS protocol
Results
Side effects
Hassler et al 
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Traumatic brain injury and utility of brain stimulation modalities tDCS studies measured cognitive function using com puterized contrast reaction time task 39 and attention/working memory task. 41 They used the JFK Coma Recovery Scale Revised to assess consciousness in persistent VS or MCS 41 and monitored improvement of motor function using func tional independence measures as a primary outcome. 45 Three LLLT/LED studies 48, 51, 62 addressed improvement of cognition after TBI, but only one study included detailed psychologi cal measurements using the Posttraumatic Stress Disorder Checklist -Civilian; the Beck Depression Inventory -II; and the Visual Analog Scale for pain.
The primary outcomes of DBS studies 23 were level of consciousness and changes in JFK Coma Recovery Scale. The secondary outcomes included neurophysiological evaluation, EEG, and auditory brainstem response. Further studies using comparable and standardized clinical and functional outcomes are warranted to investigate benefits of each brain stimulation technique for different posttraumatic conditions. In fact, some studies, especially those using NIBS, used surrogate cognitive outcomes, such as reaction time in neurophysiological tests, thus making it difficult to determine the clinical utility of these techniques. Given that functional outcomes are associated with more variability and less power, future studies need to test functional outcomes in large sample size studies.
Comparison of techniques: which one is better for TBi?
One important question is which technique is most beneficial for the treatment of TBI. Although data to date do not give enough information to respond this question, a few topics can be explored when comparing techniques: 1) efficacy of these techniques when comparing them; 2) differences of the techniques that may be advantageous for TBI treatment; and 3) safety. There is not enough evidence on efficacy to rec ommend for or against any of these techniques. Most of the studies are open label or case reports, and the few randomized controlled trials are small and/or used surrogate outcomes. Although the most remarkable clinical improvements have been shown with DBS, comparison is difficult as DBS uses longer protocols of stimulation that may be associated with larger clinical and placebo effects. Therefore, two steps are necessary to determine efficacy of these techniques: 1) development of appropriately designed placebo random ized clinical trials with large sample sizes; and 2) development of randomized clinical trials comparing these techniques.
In terms of differences between the techniques, one point for discussion is the focality. tDCS and LLLT are both nonfocal interventions, while rTMS and DBS are more focal interventions. It is unclear whether the nonfocality of tDCS and LLLT are associated with less effect. It may be argued that less focality in TBI may be beneficial to promote neuro plasticity in a wider area, or that focalization may be achieved when combined with behavioral interventions.
Regarding targeting, for the more focal techniques, there is also the question of what target is most optimal. NIBS methods may be applied over several brain areas involved in neuroplasticity processes. How the target is determined plays an important role during the stimulation. Some stud ies have stimulated the DLPFC region in order to improve neurobehavioral function, PCS, and depression. 22, 23, 26 With the development of functional imaging techniques, there are more options to achieve this goal. Reviewed rTMS studies applied navigational stimulation before and after the stimu lation to achieve the specific target 22, 24 using MRI and PET scan. This enabled visualization of the lesion and assessment of response to cortical excitability or connectivity of brain network. 21, 22, 24 DBS alters activity patterns to moderate abnormal brain function related to a specific target. Successful stimulation of the ventralis intermedius nucleus of the thalamus, reduced posttraumatic tremors, 98 and DBS targeting the subgenual cingulate cortex were used for the treatment of refractory posttraumatic depression. [99] [100] [101] In this context, development of this field will come with best definition of specific targets for specific behaviors.
The use of neurostimulation strategies and their potential role in recovery of TBI needs to be further developed. Dif ferent techniques may be optimized when used in combina tion, depending on the stage of the recovery and the specific needs of the individual. 73 In addition, the use of closed loop systems that can in real time change parameters of stimulation according to the neurophysiological response, may optimize the response to brain stimulation. Finally, the combination of chemical stimulation with drugs and brain stimulation may also result in better clinical outcomes. 102 
Safety
Considering that TBI is characterized by a chronic hyper excitability state that increases seizure risk, NIBS, especially rTMS, is regarded as a relative contraindication. In the case where there is a remarkable clinical need, the benefits may outweigh the risks of rTMS, especially when these risks can be minimized. A potential venue to reduce risk would be the use of navigated brain stimulation to ensure safely delivered stimulation to the target area, thereby reducing any adverse effects. In addition, studies 103, 104 with lowfrequency stimulation have reported antiepileptic effects. The current evidence for application of NIBS recommends exclusion of subjects with a history of seizure, subjects taking medica tions that lower seizure threshold, or those who have metal implants or brain tumors. DBS, on the other hand, is a con troversial modality due to its invasive nature. So far, this stimulation is only used on VS or MCS to regulate arousal. The guidelines of safety for each brain stimulation modality used in TBI needs to be further developed.
Conclusion
This review addresses the clinical utility of brain stimulation modalities to reduce disability and enhance recovery after TBI. Neurostimulation may be applied to a great number of debilitating neurological conditions associated with TBI. For this purpose, brain stimulation techniques may play an important role in inducing neuroplasticity and suppressing pathological disinhibition of circuits implicated in maladap tive networks. Improvements of altered state of conscious ness, cognition, and psychiatric and motor function have been the main goals of these therapeutic strategies. Although the mechanisms of neuroplasticity induced by those methods are not fully understood, these instruments have shown great potential for clinical application, significantly changing the current rehabilitation protocols of patients with neurological sequelae postTBI.
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